SCHEMBL13845256

SCHEMBL13845256

O=c1[nH]c2cnc(CC[C@@H]3CCCNC3)nc2n1C1Cc2ccccc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
JAK2 O60674 5/20 0.37
JAK3 P52333 5/20 0.37
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
KMT2A Q03164 1/20 0.35
OPRM1 P35372 2/20 0.34
OPRK1 P41145 1/20 0.34
OPRL1 P41146 1/20 0.34
MERTK Q12866 1/20 0.34
BRD4 O60885 1/20 0.34
CYP2D6 P10635 2/20 0.34
CXCR4 P61073 2/20 0.34
CHRNA1 P02708 1/20 0.34
ADRA2A P08913 1/20 0.34
ACHE P22303 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13608437 0.83 JAK2 (0.43) JAK2JAK3JAK1TYK2MERTK
SCHEMBL13608390 0.83 JAK2 (0.43) JAK2JAK3JAK1TYK2MERTK
SCHEMBL13845198 0.78 JAK2 (0.41) JAK2JAK3JAK1TYK2CYP2D6
SCHEMBL13608378 0.77 JAK2 (0.44) HRH4JAK2JAK3JAK1TYK2
SCHEMBL13608308 0.77 JAK2 (0.44) HRH4JAK2JAK3JAK1TYK2
SCHEMBL13608441 0.74 JAK2 (0.44) JAK2JAK3JAK1TYK2CYP2D6
SCHEMBL13608426 0.72 JAK2 (0.42) JAK2JAK3JAK1TYK2BRD4
SCHEMBL13608448 0.72 JAK2 (0.42) JAK2JAK3JAK1TYK2BRD4
SCHEMBL13845148 0.69 HRH3 (0.38) HRH4HRH3KMT2AOPRM1MERTK
SCHEMBL13845152 0.69 JAK2 (0.36) JAK2JAK3JAK1TYK2USP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009062059-A2 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PHARMACOPEIA, INC. (US) 2009-05-14 WO disclosed